Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 10.85
-0.55 (-4.82%)
Aug 1, 2025, 1:38 PM CST
Golden Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -360.7 | -361.64 | -271.88 | -443.84 | -391.38 | Upgrade |
Depreciation & Amortization | 44.76 | 49.25 | 49.95 | 49.38 | 54.93 | Upgrade |
Other Amortization | 1.57 | 1.78 | 1.26 | 1.81 | 1.98 | Upgrade |
Loss (Gain) From Sale of Assets | -0.15 | -1.01 | -0.44 | - | 0.48 | Upgrade |
Asset Writedown & Restructuring Costs | - | 1.68 | 2.23 | 10.01 | 27.24 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | 0.23 | - | 1.22 | Upgrade |
Stock-Based Compensation | 24.2 | - | - | 21.7 | - | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | - | -0.1 | Upgrade |
Other Operating Activities | 1.35 | -0.62 | -1.25 | 6.12 | 3.62 | Upgrade |
Change in Accounts Receivable | 0.44 | 1.02 | -0.57 | -0.77 | 2.17 | Upgrade |
Change in Inventory | 17.33 | -0.5 | 70.53 | 71.74 | 32.31 | Upgrade |
Change in Accounts Payable | -1.09 | 0.71 | 0.45 | -0.77 | -0.29 | Upgrade |
Change in Unearned Revenue | 1.42 | 2 | -113.82 | 114.13 | 0.01 | Upgrade |
Change in Other Net Operating Assets | 7.76 | 36.03 | 17.41 | -27.47 | 8.23 | Upgrade |
Operating Cash Flow | -263.11 | -271.32 | -245.9 | -197.96 | -259.6 | Upgrade |
Capital Expenditures | -0.94 | -4.89 | -14.4 | -9.34 | -9.42 | Upgrade |
Sale of Property, Plant & Equipment | 0.15 | 1.52 | 0.91 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -1.87 | -3.09 | -3.64 | -0.81 | -1.24 | Upgrade |
Other Investing Activities | -17.66 | -12.19 | 80.6 | -103.87 | -3.47 | Upgrade |
Investing Cash Flow | -20.32 | -18.64 | 63.47 | -114.02 | -14.14 | Upgrade |
Short-Term Debt Issued | 247.2 | - | - | 72 | 50 | Upgrade |
Long-Term Debt Issued | 76.06 | - | - | - | 13 | Upgrade |
Total Debt Issued | 323.26 | - | - | 72 | 63 | Upgrade |
Short-Term Debt Repaid | -235.73 | - | -2 | - | - | Upgrade |
Long-Term Debt Repaid | -35.83 | -21.8 | -24.32 | -33.73 | -37.66 | Upgrade |
Total Debt Repaid | -271.56 | -21.8 | -26.32 | -33.73 | -37.66 | Upgrade |
Net Debt Issued (Repaid) | 51.7 | -21.8 | -26.32 | 38.27 | 25.34 | Upgrade |
Issuance of Common Stock | 240 | - | - | 580 | 539.21 | Upgrade |
Financing Cash Flow | 291.7 | -21.8 | -26.32 | 618.27 | 564.55 | Upgrade |
Foreign Exchange Rate Adjustments | -0.32 | -0.85 | 0.67 | -2.65 | -0.69 | Upgrade |
Net Cash Flow | 7.96 | -312.6 | -208.08 | 303.64 | 290.12 | Upgrade |
Free Cash Flow | -264.04 | -276.2 | -260.3 | -207.31 | -269.02 | Upgrade |
Free Cash Flow Margin | -645.30% | -435.45% | -119.50% | -253.53% | -302.87% | Upgrade |
Free Cash Flow Per Share | -1.75 | -1.94 | -1.83 | -1.56 | -2.14 | Upgrade |
Cash Interest Paid | 6.99 | 6.73 | 4.08 | 3.69 | 3.13 | Upgrade |
Cash Income Tax Paid | 0.2 | 0.91 | 1.37 | 3.92 | 0.44 | Upgrade |
Levered Free Cash Flow | -139.01 | -153.2 | -98.85 | -132.66 | -168.97 | Upgrade |
Unlevered Free Cash Flow | -133.74 | -148.99 | -96.3 | -130.36 | -166.38 | Upgrade |
Change in Net Working Capital | -22.09 | -36.44 | -56.02 | -71.82 | -4.84 | Upgrade |
Updated Aug 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.